Clinical Trials Advisory Committee (CTAC)
The Clinical Trials Advisory Committee (CTAC) provides advice to the NCI Director, Deputy Directors, and Division Directors on the NCI-supported national clinical trials enterprise to build a strong scientific infrastructure by bringing together a broadly developed and engaged coalition of stakeholders involved in clinical trials. This encompasses oversight of all trials both extramural and intramural.
Roles and Responsibilities:
- Oversees implementation of the CTWG initiatives including review of the evaluation system and monitoring of the results of the evaluation over time.
- Provides oversight for use of correlative science funds called for in the CTWG report that will support specific clinical trials.
- Oversees management of clinical trials across the Institute, including on-going activities of the CTOC and the CCCT, including the clinical trials programs proposed by the CTOC.
- Advises NCI on policies, procedures, processes, tools, etc. that should be developed and implemented for prioritization, management, coordination, and administration of NCI-funded clinical trials.
- Advises the NCI Director on the status of NCI clinical trial management and administration across all Divisions/Centers/Offices including the CCCT and makes recommendations for needed improvements.
Members
last modified
2007-05-22 12:18